deltatrials
Unknown NA NCT01949922

Treatment of Fecal Incontinence by Injection of Autologous Muscle Fibers Into the Anal Sphincter

Treatment of Fecal Incontinence by Injection of Autologous Muscle Fibers Into the Anal Sphincter - a Pilot Study.

Sponsor: Herlev Hospital

Conditions Anal Incontinence Fecal Incontinence
Interventions Analgesia Dietary intervention Injection of autologous muscle fibers into the anal sphincter. Pelvic floor muscle training
Updated 6 times since 2017 Last updated: Feb 18, 2016 Started: Apr 30, 2013 Primary completion: Jan 31, 2017 Completion: Jan 31, 2018

This NA trial investigates Anal Incontinence and Fecal Incontinence and is currently ongoing. Herlev Hospital leads this study, which shows 6 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown NA

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status NA

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status NA

  5. Mar 2018 — Jun 2018 [monthly]

    Unknown Status NA

    Status: Recruiting → Unknown Status

▶ Show 1 earlier version

  1. Jan 2017 — Mar 2018 [monthly]

    Recruiting NA

    First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Herlev Hospital
Data source: Herlev Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Copenhagen, Denmark